Page 1 of Clinical Trials for Other laboratory biomarker analysis, 1512 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Diseases Undergoing Donor Peripheral Blood Stem Cell Transplant
Last Updated: September 26, 2011
Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
2
Not yet recruiting
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
Last Updated: January 13, 2012
Condition(s): Leukemia
3
Completed
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
Last Updated: May 17, 2011
Condition(s): Head and Neck Cancer
4
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Last Updated: February 5, 2012
Condition(s): Chordoma; Desmoid Tumor; Sarcoma
5
Active, not recruiting
Sunitinib Malate and Bevacizumab in Treating Patients With Metastatic Kidney Cancer and Other Advanced Solid Malignancies
Last Updated: January 10, 2012
Condition(s): Hereditary Clear Cell Renal Cell Carcinoma; Kidney Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
6
Recruiting
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Last Updated: June 9, 2009
Condition(s): Breast Cancer
7
Recruiting
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Last Updated: April 20, 2010
Condition(s): Brain and Central Nervous System Tumors
8
Recruiting
Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Last Updated: October 8, 2010
Condition(s): Kidney Cancer; Unspecified Adult Solid Tumor, Protocol Specific
9
Completed
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
Last Updated: November 20, 2009
Condition(s): Breast Cancer
10
Recruiting
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed By a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Last Updated: January 23, 2012
Condition(s): Precancerous Condition
11
Recruiting
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
Last Updated: July 7, 2009
Condition(s): Leukemia; Myelodysplastic Syndromes
12
Recruiting
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
Last Updated: August 21, 2010
Condition(s): Hereditary Multiple Melanoma; Melanoma (Skin)
13
Recruiting
Cyclophosphamide, Fludarabine, Total-Body Irradiation, and Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer or Other Disease
Last Updated: July 7, 2009
Condition(s): Leukemia; Lymphoma; Myelodysplastic Syndromes
14
Recruiting
Montelukast to Treat Bronchiolitis Obliterans
Last Updated: December 29, 2011
Condition(s): Bronchiolitis Obliterans; Chronic Graft Versus Host Disease; Leukotriene; Montelukast; Stem Cell Transplant
15
Recruiting
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
Last Updated: November 4, 2011
Condition(s): Graft Versus Host Disease; Infection; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
16
Recruiting
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
Last Updated: August 15, 2011
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
17
Recruiting
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Last Updated: January 22, 2011
Condition(s): Brain and Central Nervous System Tumors
18
Active, not recruiting
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
Last Updated: February 10, 2011
Condition(s): Leukemia
19
Active, not recruiting
DNA Changes as a Risk Factor for Barrett's Esophagus in Patients With Barrett's Esophagus, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Last Updated: February 1, 2010
Condition(s): Precancerous Condition
20
Active, not recruiting
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Last Updated: June 27, 2011
Condition(s): Brain and Central Nervous System Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Other+laboratory+biomarker+analysis

Page 1 of Clinical Trials for Other laboratory biomarker analysis, 1512 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About